3D Interaction,drug ligand name,target,Uniprot code,n_ca_T,n_ca_M,n_local_pairs,local_rmsd,local_coverage,vendor,smiles,clinical_phase,moa,database,cids,target chain id,chain name,Align Length,Binding_Affinity_kcal/mol
2UW7_GVP_P62343.pdb,GVP,2UW7,P62343,335,524,156,0.681,0.466,Selleck,Clc1ccc(cc1)C1(CCNCC1)c1ccc(cc1)-c1cn[nH]c1,Preclinical,AKT inhibitor,Uniprot,11175137,A,protein kinase [Plasmodium falciparum],260,-8.706
2UW9_GVP_P62343.pdb,GVP,2UW9,P62343,316,524,144,0.726,0.456,Selleck,Clc1ccc(cc1)C1(CCNCC1)c1ccc(cc1)-c1cn[nH]c1,Preclinical,AKT inhibitor,Uniprot,11175137,A,protein kinase [Plasmodium falciparum],276,-9.443
2UW9_GVP_O15906.pdb,GVP,2UW9,O15906,316,342,191,0.678,0.604,Selleck,Clc1ccc(cc1)C1(CCNCC1)c1ccc(cc1)-c1cn[nH]c1,Preclinical,AKT inhibitor,Uniprot,11175137,A,cAMP-dependent protein kinase [Plasmodium falciparum],297,-7.812
